Skip to content

Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients

Acute and Medium-term Effects of Neuromuscular Electrical Multisite System (Kneehab®) on Cardiovascular Parameters and Induced Muscle Fatigue in Morbidly Obese Patients: Comparison With the Unidirectional Standard Device

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01820598
Acronym
StimobII
Enrollment
30
Registered
2013-03-29
Start date
2013-01-31
Completion date
2017-12-31
Last updated
2017-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Cardiovascular, Electrical Stimulation, Obesity, Training

Brief summary

The study was designed to test the following hypotheses: In patients with severe obesity, a multisite electrostimulation session (m-NMES) will induce higher changes in metabolic, inflammatory and cardiovascular parameters and higher increase in muscle strength during stimulated contractions than conventional unidirectional electrostimulation session (c-NMES). In patients with severe obesity, a six-weeks m-NMES training program will enhance cardiovascular, metabolic and inflammatory parameters.

Detailed description

Background: Physical activity is known to reduce cardiovascular risk as far as even minor change in lifestyle could occur. In obesity, physical activity programs remain challenging due to multifactorial causes related to body mass such as shortness of breath, traumatological pain or psychosocial causes. Although neuromuscular electrical stimulation training is presently ignored in the management of obesity, this technique may be appropriate and useful for muscle deconditioning in these patients. Furthermore, direct effects of electrostimulation training program on vascular function have been previously reported in spinal cord injury and chronic heart disease, suggesting that improvement in cardiovascular function may be expected. While a promising new technique of multisite electrical stimulation (the Kneehab® system) has been recently commercialized, few study have investigated the acute effects of electrostimulation on vascular function and not any study report the effects of electrical stimulation in obese patients. MAIN OUTCOME OF THE ACUTE PHASE STUDY (1st part):To study the effect of multisite electrical stimulation session (m-NMES) on arterial stiffness as compared to conventional unidirectional electrical stimulation session (c-NMES) in patients with severe obesity. Secondary outcomes of the observational study: 1/ To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as electrically-induced muscle fatigue as compared with c-NMES in patients with morbid obesity. 2/ To study the profile of responders to electrical stimulation according to body composition, 6-minute walking distance, spontaneous physical activity or susceptibility to tolerate electrical stimulation. Response to electrical stimulation will be assessed by an improvement in arterial stiffness after stimulation, if so. MAIN OUTCOME OF THE INTERVENTIONAL STUDY (2nd part):To study the effect of a multisite electrical stimulation training program (m-NMES) (6 weeks, 30 sessions) on arterial stiffness in patients with severe obesity. Secondary outcomes of the interventional study: To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as muscle strength, body composition, functional capacity (6-minute walking distance) and spontaneous physical activity, after 15 sessions (3 weeks) and after 30 sessions (6 weeks) of training program. Evaluation of the dose-response to m-NMES training in terms of arterial stiffness and functional capacity. Expected outcomes: Acute change in arterial stiffness and/or endothelial function is expected after one m-NMES session and/or after c-NMES session. M-NMES session is expected to induce higher changes than c-NMES stimulation session on cardiovascular and muscle parameters. Chronic changes in arterial stiffness and/or endothelial function is expected after 6 weeks of m-NMES training.

Interventions

DEVICEMultisite NMES training during 6 weeks

Sponsors

University Hospital, Grenoble
CollaboratorOTHER
AGIR à Dom
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, aged over 18 years * Morbid obesity (BMI \> 35 kg/m²) * Not included into exercise training program in the year prior to inclusion- Spontaneous physical activity lower than 160 min wk (i.e. \< 30 min/d x 5 d/wk). Additional Inclusion criteria for the interventional study: * Patients with PWV \> 9.3 m / s

Exclusion criteria

* Underage- Pregnant or parturient women * Persons deprived of their liberty for judicial or administrative reasons, person under a legal protection measure (article L1121-8) * Exclusion period in other studies- Person not affiliated to a social security scheme * Chronic alcoholism

Design outcomes

Primary

MeasureTime frameDescription
Delta arterial stiffnessDay1 and Day3Change in carotid-femoral Pulse wave velocity (PWV) after NMES sessions

Secondary

MeasureTime frameDescription
Delta pulse arterial tonus (RH-PAT)Day1 and Day3change in pulse arterial tonometry after NMES sessions
NMES-induced muscle fatigueDay1 and Day3change in maximal voluntary contraction after NMES sessions
Delta blood pressureDay1 and Day3changes in systolic and diastolic blood pressures after NMES sessions
Body compositionDay1, Day21 and Day 42Fat-free mass and fat-free mass indexes assessed by impedancemetry
Spontaneous physical activityDay1 and Day 42Number of hours per day of physical activity at 1, 2, 3, 4 or 5 metabolic equivalent(METS),Number of step per day,using a 7-days actigraphy
Maximal voluntary contractionDay1, Day21 and Day 42Quadriceps peak force
Delta plasmatic biomarkersDay1 and Day3changes in inflammatory and metabolic plasmatic biomarkers after NMES sessions
Arterial stiffnessDay1, Day21 and Day 42Pulse wave velocity (PWV) measurements
Pulse artery tone (RH-PAT)Day1, Day21 and Day 42Pulse artery tonometry measurement
Plasmatic biomarkersDay1, Day21 and Day 42Inflammatory and metabolic biomarkers
Blood pressureDay1, Day21 and Day 42Arterial systolic and diastolic blood pressure
Response to m-NMESDay42Delta in current intensity during m-NMES between the first to the last session
Walking distanceDay1 and Day 426-minute-walking test

Countries

France

Contacts

Primary ContactJean-Louis Pepin, MD, PhD
JPepin@chu-grenoble.fr476765516
Backup ContactIsabelle Vivodtzev, PhD
i.vivodtzev@agiradom.com476510304

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026